Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-22-029439)

Filing Details

Accession Number:: 0000899243-22-029439
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-22 16:30:40
Reporting Period:: 2022-08-18

Accepted Time:: 2022-08-22 16:30:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521036	Lantheus Holdings Inc.	LNTH	In Vitro & In Vivo Diagnostic Substances (2835)	352318913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1801395	Paul Blanchfield	C/O Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica MA 01862	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-08-18	1,500	$83.39	76,143	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2022.
Includes 286 shares acquired under the LNTH employee stock purchase plan on March 11, 2022.